A new study published in Dermatologic Surgery in April suggests platelet-rich plasma (PRP) has a positive effect on androgenetic alopecia (AGA).
US hair loss technology provider Kerastem has confirmed that patients who underwent the Phase 2 clinical trial in early-stage hair loss achieved an increase in mean terminal hair count in men with early hair loss when compared to the control group. Based on these results, Kerastem plans to begin a Phase 3 clinical trial later this year.
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.
A new drug has been developed that aims to mimic sunlight and cause the skin to tan without the damaging effects of UV radiation.
Aesthetic practitioners from across the country gathered at the Crowne Plaza London City hotel on November 23 for the launch of the Biofibre Hair Implantation device.
A study published in the American Journal of Clinical Nutrition has indicated that vitamin D2 and D3 do not have the same nutritional value.
Aesthetic manufacturer SkinGen UK has launched the SkinGenuity Hair Restoration Home Kit which aims to stimulate hair growth.
Aesthetic product supplier CACI International has released new statistics following a clinical study that took place on 25 female participants trialing the new Simultaneous Photo Electrical Delivery (S.P.E.D) technology.
A new study has suggested that the use of cosmeceutical company SkinCeuticals’ H.A. Intensifier on eyes and lips has demonstrated visible improvement in lip plumpness and reduction of under-eye hollows.
A study published by the Journal of Investigative Dermatology has revealed promising results for a new vaccine that could prevent acne vulgaris.